Beta-thalassemia intermedia: an overview.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Pediatric annals

• Publication date

  2008-05-01

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.3928/00904481-20080501-06PMID 18543543
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucose-6-phosphate dehydrogenase deficiency

  2008cited by this paper
• Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran

  2006cited by this paper
• Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance.

  2005cited by this paper
• Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia.

  2005cited by this paper
• Hematologic and Clinical Responses of Thalassemia Intermedia Patients to Hydroxyurea During 6 Years of Therapy in Iran

  2005cited by this paper
• Osteoporosis in beta-thalassemia: Clinical and genetic aspects.

  2005cited by this paper
• Hydroxyurea in thalassemia intermedia—a promising therapy

  2005cited by this paper
• Overcoming the challenge of patient compliance with iron chelation therapy.

  2005cited by this paper
• Red cell pyruvate kinase deficiency: molecular and clinical aspects

  2005cited by this paper
• Intrathoracic masses due to extramedullary hematopoiesis.

  2004cited by this paper
• Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients

  2003cited by this paper
• Anemia and the liver. Hepatobiliary manifestations of anemia.

  2002cited by this paper
• A single mutation 202G>A in the human glucose-6-phosphate dehydrogenase gene (G6PD) can cause acute hemolysis by itself.

  2002cited by this paper
• The hypercoagulable state in thalassemia.

  2002cited by this paper
• Iron status and HFE genotype in erythrocyte pyruvate kinase deficiency: study of Italian cases.

  2001cited by this paper
• Cardiac involvement in thalassemia intermedia: a multicenter study.

  2001cited by this paper
• Successful bone marrow transplantation in a child with red blood cell pyruvate kinase deficiency

  2000cited by this paper
• Chronic non-spherocytic haemolytic disorders associated with glucose-6-phosphate dehydrogenase variants.

  2000cited by this paper
• Biochemical and genetic basis of red cell enzyme deficiencies.

  2000cited by this paper
• Glucose-6-phosphate dehydrogenase deficiency.

  2000cited by this paper
• Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia.

  2000cited by this paper
• The interaction between Gilbert's syndrome and G6PD deficiency influences bilirubin levels.

  1999cited by this paper
• Glucose-6-phosphate dehydrogenase deficiency and malaria

  1998cited by this paper
• Hematologically important mutations: red cell pyruvate kinase (2nd update).

  1998cited by this paper
• Molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) variants in Italy.

  1997cited by this paper
• G6PD: population genetics and clinical manifestations.

  1996cited by this paper
• Conjugated bilirubin in neonates with glucose-6-phosphate dehydrogenase deficiency.

  1996cited by this paper
• Hematologically important mutations: glucose-6-phosphate dehydrogenase.

  1996cited by this paper
• A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.

  1993cited by this paper
• Iron status in red cell pyruvate kinase deficiency: study of Italian cases

  1993cited by this paper
• Both mutations in G6PD A- are necessary to produce the G6PD deficient phenotype.

  1992cited by this paper
• Structural analysis of human pyruvate kinase L-gene and identification of the promoter activity in erythroid cells.

  1992cited by this paper
• Prenatal diagnosis of glucose-6-phosphate-dehydrogenase deficiency.

  1992cited by this paper
• A logical approach to the investigation of red cell enzymopathies.

  1990cited by this paper
• Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group.

  1989cited by this paper
• Human liver type pyruvate kinase: complete amino acid sequence and the expression in mammalian cells.

  1988cited by this paper
• Improved erythrocyte survival with combined vitamin E and selenium therapy in children with glucose-6-phosphate dehydrogenase deficiency and mild chronic hemolysis.

  1986cited by this paper
• Hemolytic anemias and erythrocyte enzymopathies.

  1985cited by this paper
• Tissue-specific levels of human glucose-6-phosphate dehydrogenase correlate with methylation of specific sites at the 3' end of the gene.

  1985cited by this paper
• Juvenile leg ulceration in beta-thalassemia major and intermedia.

  1982cited by this paper
• Characterization of pyruvate kinase from the liver of a patient with aberrant erythrocyte pyruvate kinase, PK Nagasaki.

  1977cited by this paper
• Intracellular restraint: a new basis for the limitation in response to oxidative stress in human erythrocytes containing low-activity variants of glucose-6-phosphate dehydrogenase.

  1974cited by this paper
• Glucose-6-phosphate dehydrogenase and malaria. Greater resistance of females heterozygous for enzyme deficiency and of males with non-deficient variant.

  1972cited by this paper
• A specific erythrocyte glycolytic enzyme defect (pyruvate kinase) in three subjects with congenital non-spherocytic hemolytic anemia.

  1961cited by this paper
• The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character.

  1954cited by this paper

• Neurotherapy as a Complementary Approach for Beta-Thalassemia Intermedia

  2025cites this paper
• Cognitive performance, mental health, and quality of life in β-thalassemia individuals: a comprehensive analysis

  2024cites this paper
• Relationship between liver iron concentration determined by R2-MRI, serum ferritin, and liver enzymes in patients with thalassemia intermedia

  2018cites this paper
• B-thalassemia intermedia in Babylon Thalassemic centre Babil , Iraq .

  2017cites this paper
• A Rare Case of Co-Inheritance of Beta Thalassemia Intermedia and Coagulation FVII Deficiency

  2017cites this paper
• Thalassemia Intermedia; Folic Acid and Vitamin B12 Supplementation. What We Know and What is Needed?

  2017cites this paper
• Prevalence and Risk Factors for Complications in Patients with Nontransfusion Dependent Alpha- and Beta-Thalassemia

  2015cites this paper
• Guidelines for Diagnosis and Management of Beta-Thalassemia Intermedia

  2014cites this paper
• Dental Management of Frequent Childhood Hemoglobinopathies

  2014cites this paper
• Relationship Between Iron and Erythropoiesis

  2012cites this paper
• Clinicopathological and Radiological Study of Egyptian β-Thalassemia Intermedia and β-Thalassemia Major Patients: Relation to Complications and Response to Therapy

  2011cites this paper
• Complications of β-Thalassemia Intermedia in Iran During 1996–2010 (Single-Center Study)

  2011influential citation
• Comparative study of pulmonary circulation and myocardial function in patients with β‐thalassemia intermedia with and without hydroxyurea, a case–control study

  2011cites this paper
• Ferroportin and Erythroid Cells: An Update

  2010cites this paper
• Percutaneous aortic valve replacement in a 65-year old patient with thalassemia intermedia: A case report.

  2010cites this paper
• Echocardiographic finding in beta‐thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta‐thalassemia intermedia

  2009influential citation
• Extramedullary hematopoiesis within paravertebral masses demonstrating prominent sestamibi and thallium uptake.

  2009cites this paper
• Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions

  2009cites this paper
• Effect of folic acid supplementation in a young thalassaemia intermedia patient with folate deficiency and subfertility

  2009cites this paper
• A Case of β Thalassemia Intermedia Due to Hemoglobin Cagliari (β 60 Val→Glu)

  2009cites this paper